A cell line expressing both the beta-lactamase (BLA) reporter-gene under control of the cAMP Response Element (CRE) promoter and the human S1P2 receptor was used to measure S1P2 agonism. Under normal conditions, S1P2 has low basal activity and therefore cells express low BLA levels. When the S1P2 receptor is stimulated by an agonist, transcription of the BLA gene occurs proportionally to agonist concentration, and BLA activity in the sample is increased. This increase is monitored by measuring fluorescence resonance energy transfer (FRET) of a cleavable fluorogenic cell permeable BLA substrate. For this assay, a Chinese Hamster Ovary (CHO) cell line stably transfected with  human S1P2 receptor and a cAMP Response Element-beta lactamase (CRE-BLA) reporter construct was used. Cells were routinely cultured in T-175 sq cm flasks (Corning, part 431080) at 37 deg C and 95% relative humidity (RH). The growth media consisted of Dulbecco's Modified Eagle's Media supplemented with 10% v/v heat inactivated dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 2 mg/mL Geneticin and 1X antibiotic mix (mix of penicillin, streptomycin and neomycin). Prior to assay, cells were suspended to a concentration of 1.25 million/milliliter in assay media, which consisted of phenol red-free Dulbecco's Modified Eagle's Media supplemented with 2% charcoal/dextran-treated fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine and 1X antibiotic mix (mix of penicillin, streptomycin and neomycin). The assay began by dispensing 4 microliters of cell suspension to each test well of a 1536 well plate (5000 cells/well) followed by incubation at 37 deg C in 5% CO2 for 16 hrs. To the appropriate wells were then added 26 nL of test compound in DMSO (final nominal concentration of 4.5 micromolar, final DMSO concentration of 0.5%) or DMSO only (for negative control wells) followed directly afterwards by 1 microliter of 2% BSA. The S1P positive control was also added to the appropriate control wells to a final concentration of 3.3 micromolar, i.e. a concentration that resulted in 100% activity (EC100). Plates were incubated again at 37 deg C in 5% CO2 for 2 hrs. The fluorogenic LiveBLAzer substrate mixture with 10 mM Probenicid was prepared according to the manufacturer's protocol and this mixture was then added (1 microliter/well). After a further 2 hours of incubation at room temperature, plates were read on the EnVision plate reader (PerkinElmer Lifesciences, Turku, Finland) at an excitation wavelength of 405 nm and emission wavelengths of 535 nm & 460 nm. Fluorescence values measured for each channel were corrected by subtracting "background" fluorescence, i.e. fluorescence measured in wells containing media and substrate only. To normalize assay data, values measured from both the probe's fluorescence emission wavelengths were used to calculate a ratio for each well, according to the following mathematical expression: Ratio = I460 nm/I535 nm where I represents the measured fluorescence emission intensity at the enumerated wavelength in nanometers. Percent activation was calculated from the median ratio as follows: %Activation= ((Ratio_Test_Compound- Median_Ratio_Low_Control)/(Median_Ratio_High_Control - Median_Ratio_ Low_Control))*100 Where: Low Control: 2% fatty acid free BSA (Calbiochem, part#126609) High Control: 3.3 micromolar of S1P, corresponding to its EC100 (Biomol, part#SL-140) A mathematical algorithm was used to determine nominally activating compounds in the primary screen. Two values were calculated: (1) the average percent activation of all compounds tested, and (2) three times their standard deviation. The sum of these two values was used as a cutoff parameter, i.e. any compound that exhibited greater %activation than the cutoff parameter was declared active. List of reagents: Dulbecco's Modified Eagle's Media with phenol red (Invitrogen, part 11965-092) Dulbecco's Modified Eagle's Media without phenol red (Invitrogen, part 21063-029) Fetal Bovine Serum (Invitrogen, part 26400-044) NEAA (Invitrogen, part 1114-050) Sodium Pyruvate (Invitrogen, part 11360-070) HEPES (Invitrogen, part 15630-080) L-Glutamine (Invitrogen, part 25030-081) Geneticin (Invitrogen, part 10131-027) 100X Penicillin-Streptomycin-Neomycin mix (Invitrogen, part 15640-055). Charcoal/dextran treated fetal bovine serum (Hyclone, part SH30068.03) Probenicid (Sigma, part P8761) S1P agonist (Biomol, part#SL-140) LiveBLAzer (Invitrogen, part K1096)
bao:BAO_0001067 "843" ; # "is primary assay of" -> "843"
bao:BAO_0001067 "854" ; # "is primary assay of" -> "854"
bao:BAO_0001067 "872" ; # "is primary assay of" -> "872"
bao:BAO_0001067 "874" ; # "is primary assay of" -> "874"
bao:BAO_0000808 bao:BAO_0000031 ; # "has primary assay" -> "primary assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "beta lactamase reporter gene" ; # "is bioassay type of" -> "beta lactamase reporter gene"
bao:BAO_0000212 bao:BAO_0000125 ; # "has assay method" -> "reporter gene method"
bao:BAO_0000212 bao:BAO_0000151 ; # "has assay method" -> "beta lactamase induction"
bao:BAO_0000207 bao:BAO_0000001 ; # "has detection method" -> "fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Agonists of the Sphingosine 1-Phosphate Receptor 2 (S1P2)" ; # "screening campaign name" -> "Agonists of the Sphingosine 1-Phosphate Receptor 2 (S1P2)"
bao:BAO_0002853 "Primary Cell-Based High-Throughput Screening to Identify Agonists of the Sphingosine 1-phosphate receptor 2 (S1P2)" ; # "has assay title" -> "Primary Cell-Based High-Throughput Screening to Identify Agonists of the Sphingosine 1-phosphate receptor 2 (S1P2)"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "25 degree celsius" ; # "substrate incubation temperature" -> "25 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2 hour" ; # "substrate incubation time" -> "2 hour"
bao:BAO_0002833 "4 hour" ; # "has incubation time value" -> "4 hour"
bao:BAO_0002857 "\"S1P, S1P2 agonist, 3.3 micromolar EC100\"" ; # "has signal direction" -> ""S1P, S1P2 agonist, 3.3 micromolar EC100""
bao:BAO_0000740 bao:BAO_0000156 ; # "has assay control" -> "high signal control"
bao:BAO_0002857 "2% BSA" ; # "has signal direction" -> "2% BSA"
bao:BAO_0000740 bao:BAO_0000168 ; # "has assay control" -> "low signal control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "TSRI" ; # "material entity assay provider" -> "TSRI" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0002000 bao:BAO_0000998 ; # "has measured entity" -> "Probenecid" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BA0_0090012 "Sphingosine 1-phosphate receptor 2" ; # "has participant" -> "Sphingosine 1-phosphate receptor 2"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0002421> ; # "has cell line" -> "CHO cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "O95136" ; # "uniprot ID" -> "O95136"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% v/v heat inactivated dialyzed fetal bovine serum" ; # "material entity culture serum" -> "10% v/v heat inactivated dialyzed fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"DMEM with 10% v/v heat inactivated dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 2 mg/mL Geneticin and 1x penicillin-streptomycin-neomycin\"" ; # "material entity culture medium" -> ""DMEM with 10% v/v heat inactivated dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 2 mg/mL Geneticin and 1x penicillin-streptomycin-neomycin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"Phenol red free DMEM with 2% charcoal/dextran treated fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 5 mM L-Glutamine and 1x antibiotic mix (penicillin, streptomycin, neomycin)\"" ; # "has assay medium" -> ""Phenol red free DMEM with 2% charcoal/dextran treated fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 5 mM L-Glutamine and 1x antibiotic mix (penicillin, streptomycin, neomycin)""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2% charcoal/dextran treated fetal bovine serum" ; # "material entity assay serum" -> "2% charcoal/dextran treated fetal bovine serum"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "\"Expressing the human S1P2 receptor, G-alpha-15 and beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)\"" ; # "DNA construct" -> ""Expressing the human S1P2 receptor, G-alpha-15 and beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)""
bao:BAO_0003105 "sphingosine-1-phosphate receptor 2" ; # "has function" -> "sphingosine-1-phosphate receptor 2"
bao:BAO_0003105 "\"guanine nucleotide binding protein (G protein), alpha 15 (Gq class)\"" ; # "has function" -> ""guanine nucleotide binding protein (G protein), alpha 15 (Gq class)""
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9294" ; # "construct gene ID" -> "9294"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2769" ; # "construct gene ID" -> "2769"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0003105 bao:BAO_00020151 ; # "has function" -> "artificial regulatory region"
bao:BAO_0003105 "Nuclear factor of activated T-cells" ; # "has function" -> "Nuclear factor of activated T-cells"
bao:BAO_0003105 bao:BAO_0000751 ; # "has function" -> "Beta-lactamase" || bao:BAO_0003102 bao:BAO_0002656 ; # "has role" -> "reporter gene"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000751 ; # "has participant" -> "Beta-lactamase"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0002153 ; # "has signal direction" -> "signal increase corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000958 ; # "has assay kit" -> "LiveBLAzer FRET - B/G Loading Kit"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000677 ; # "has manufacturer" -> "Invitrogen" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000648 bao:BAO_0000733 ; # "compound library" -> "MLSMR library"
bao:BAO_0002865 bao:BAO_0000701 ; # "uses detection instrument" -> "EnVision Multilabel Reader"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "405 nanometer" ; # "has excitation wavelength value" -> "405 nanometer"
bao:BAO_0002918 "460 nanometer" ; # "has emission wavelength value" -> "460 nanometer"
bao:BAO_0002918 "535 nanometer" ; # "has emission wavelength value" -> "535 nanometer"
bao:BAO_0000337 bao:BAO_0000200 ; # "has percent response" -> "percent activation"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "4.5" ; # "has concentration value" -> "4.5"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0002845 "1" ; # "has repetition point-number" -> "1"
bao:BAO_0000196 bao:BAO_0000087 ; # "has mode of action" -> "activation"
bao:BAO_0002864 bao:BAO_0000136 ; # "has repetition throughput" -> "single repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
